Skip to content

Women At Risk: The High Risk Breast Cancer Program

Women At Risk: The High Risk Breast Cancer Program

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01034891
Acronym
WAR
Enrollment
2000
Registered
2009-12-18
Start date
1991-01-31
Completion date
Unknown
Last updated
2009-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

BRCA mutation, benign breast disease, family history of breast cancer, strong family history of breast cancer, atypical ductal hyperplasia, atypical lobular hyperplasia, high risk for breast cancer

Brief summary

The purpose of this study is to increase understanding of women who are at high risk for developing breast cancer. Data from this group will be collected and entered into a registry. This registry serves as a clinical database to support research in prevention, early detection and treatment of breast cancer.

Detailed description

This is a longitudinal cohort study that collects data of eligible women at risk for developing breast cancer. Patient information will be entered into a secured computerized database that is used for research on the prevention, early detection and treatment of breast cancer.

Interventions

None listed

Sponsors

Women At Risk
CollaboratorAMBIG
New York Presbyterian Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* one or more first-degree relatives (mother, daughter, or sister) with pre-menopausal breast cancer * two or more first-degree relatives with post-menopausal breast cancer * tested positive for a BRCA1 or BRCA2 mutation * a history of biopsy-proven atypical ductal hyperplasia or atypical lobular hyperplasia * a history of biopsy-proven lobular neoplasia (lobular carcinoma in situ)

Exclusion criteria

* DCIS (ductal carcinoma in situ) * previous diagnosis of breast cancer

Countries

United States

Contacts

Primary ContactAmy C Whiffen, MPH
awhiffen@womenatrisknyc.org212-305-3238
Backup ContactLisa Held, BA
lheld@womenatrisknyc.org212-305-3269

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026